Increased pregnancy rates after ultralong postoperative therapy with gonadotropin-releasing hormone analogs in patients with endometriosis

Dagmar Rickes, Ingrid Nickel, Siegfried Kropf, J. Kleinstein, Jürgen Kleinstein
Fertility and Sterility · 2002 · vol. 78(4) , pp. 757–762 · doi:10.1016/s0015-0282(02)03338-1 · PMID:12372452 · W2044680882
article OA: closed CC0 ⤵ 104 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-06 ⓘ

This study investigated whether ultralong postoperative therapy with gonadotropin-releasing hormone analogs increases pregnancy rates in patients with endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

mesh:D004715endometriosis

MeSH descriptors

Endometriosis Endometriosis Goserelin Adult Endometriosis Female Fertilization in Vitro Goserelin Goserelin Humans Insemination, Artificial, Homologous Postoperative Period Pregnancy Prospective Studies Sperm Injections, Intracytoplasmic Time Factors Treatment Outcome

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (17)

Cited by (50)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:13:01.552487+00:00
License: CC0 · commercial use OK